RxDoctor Payments DataLook up a doctor →

James Henderson, MD

Adolescent Medicine · Columbia, SCNPI 1689840514

Payments from drug & device makers

$6,933in general payments, 2019–2025

Across 397 payments — averaging $17.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$889
  • Amgen$613
  • Lilly USA, LLC$403
  • Dexcom, Inc.$272
  • Sanofi-aventis U.S. LLC$256
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$6,933100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,933 in reported general payments places this provider in the 90th percentile of 28 adolescent medicine providers in South Carolina.

See all adolescent medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$240,047
Medicare patients
383
Services billed
10,199

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide34$49,696
JardianceEmpagliflozin25$37,311
TrulicityDulaglutide17$32,313
OzempicSemaglutide23$26,904
EliquisApixaban18$13,299
MyrbetriqMirabegron11$7,800
Lantus SolostarInsulin Glargine,hum.Rec.Anlog26$5,442
Humalog Kwikpen U-100Insulin Lispro13$4,065
Memantine Hcl45$3,730
Atorvastatin Calcium190$3,136
Donepezil Hcl64$2,966
Albuterol Sulfate HfaAlbuterol Sulfate32$2,313
Venlafaxine Hcl ErVenlafaxine Hcl52$2,216
Levothyroxine Sodium117$2,205
Icosapent Ethyl12$2,196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$403$82,00951 claims
Boehringer IngelheimJardiance$222$37,31125 claims
Novo NordiskOzempic$889$26,90423 claims
PfizerEliquis$239$13,29918 claims
Astellas Pharma US IncMyrbetriq$33$7,80011 claims
AbbVieSynthroid$214$1,31523 claims
Scilex Pharmaceuticals Inc.Colchicine$48$1,01324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 28 adolescent medicine providers in South Carolina.

Other adolescent medicine in Columbia

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →